Ghofrani H, Simonneau G, D'Armini AM, et al. Efficacy and Safety of Macitentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from the Randomized Controlled MERIT Study. ATS 2017, A7601.
Combinatie JAK-remmer en anti-PD-1 bij gemetastaseerd NSCLC
sep 2024 | Immuuntherapie, Longoncologie